Design and synthesis of a 3,4-dehydroproline amide discovery library

Journal of Combinatorial Chemistry

Volumn 9, Issue 4, 2007, Pages 677-683

  Werner, Stefan ^a   Kasi, Dhanalakshmi ^a   Brummond, Kay M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; DRUG DERIVATIVE; PROLINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; FACTUAL DATABASE; ISOLATION AND PURIFICATION; PHYSICAL CHEMISTRY; SYNTHESIS;

AMIDES; CHEMISTRY, PHYSICAL; DATABASES, FACTUAL; MOLECULAR STRUCTURE; PROLINE;

EID: 34547224019     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc070011p     Document Type: Article

References (41)

1. For a review on naturally occurring proline analogues, see: Mauger, A. B. J. Nat. Prod. 1996, 59, 1205-1211.
2. Moore, S.; Felix, A. M.; Meienhofer, J.; Smith, C. W.; Walter, R. J. Med. Chem. 1977, 20, 495-500.
3. (a) Smith, C. W.; Walter, R. Science 1978, 199, 297-299.
4. (b) Botos, C. R.; Smith, C. W.; Chan, Y. L.; Walter, R. J. Med. Chem. 1979, 22, 926-931.
5. (a) Fisher, G. H.; Marlborough, D. I.; Ryan, J. W.; Felix, A. M. Arch. Biochem. Biophys. 1978, 189, 81-85.
6. (b) Fisher, G. H.; Ryan, J. W. FEBS Lett. 1979, 107, 273-276.
7. Cooper, J. B.; Varner, J. E. Plant Physiol. 1983, 73, 324-328.
8. Salvador, R. A.; Tsai, I.; Marcel, R. J.; Felix, A. M.; Kerwar, S. S. Arch. Biochem. Biophys. 1976, 174, 381-392.
9. Amoscato, A. A.; Babcock, G. F.; Nishioka, K. Peptides 1984, 5, 489-494.
10. (a) Lange, U. E. W.; Zechel, G Bioorg. Med. Chem. Lett. 2002, 12, 1571-1573.
11. (b) Bernard, H.; Billow, G.; Lange, U. E. W.; Mack, H.; Pfeiffer, T.; Schäfer, B.; Seitz, W.; Zierke, T. Synthesis 2004, 14, 2367-2375.
12. (c) Mack, H.; Baucke, D.; Hornberger, W.; Lange, U. E. W.; Seitz, W.; Höffken, H. W. Bioorg. Med. Chem. Lett. 2006, 16, 2641-2647.
13. (d) Lange, U. E. W.; Baucke, D.; Hornberger, W.; Mack, H.; Seitz, W.; Höffken, H. W. Bioorg. Med. Chem. Lett. 2006, 16, 2648-2653.
14. Chiba, J.; Machinaga, N.; Takashi, T.; Ejima, A.; Takayama, G.; Yokoyama, M.; Nakayama, A.; Baldwin, J. J.; McDonald, E.; Saionz, K. W.; Swanson, R.; Hussain, Z.; Wong, A. Bioorg. Med. Chem. Lett. 2005, 15, 41-45.
15. (a) Culvenor, C. C. J.; Cockrum, P. A.; Edgar, J. A.; Frahn, J. L.; Gorst-Allman, C. P.; Jones, A. J.; Marasas, W. F. O.; Murray, K. E.; Smith, L. W.; Steyn, P. S.; Vieggaar, R.; Wessels, P. L. J. Chem. Soc., Chem. Commun. 1983, 1259-1262.
16. (b) Ludueña, R. F.; Prasad, V.; Roach, M. C.; Lacey, E. Arch. Biochem. Biophys. 1989, 272, 32-38.
17. (c) Chaudhuri, A. R.; Ludueña, R. F. J. Protein Chem. 1997, 16, 99-105.
18. (d) Yu, M.; Than, K.; Colegate, S.; Shiell, B.; Michalski, W. P.; Prowse, S.; Wang. L. F. Mol. Diversity 2005, 9, 233-240.
19. Mues, H.; Kazmaier, U. Synthesis 2001, 487-498.
20. (a) Ishii, K.; Ohno, H.; Takemoto, Y.; Ibuka, T. Synlett 1999, 228-230.
21. (b) Ishii, K.; Ohno, H.; Takemoto, Y.; Osawa, E.; Yamaoka, Y.; Fujii, N.; Ibuka, T. J. Chem. Soc., Perkin Trans. 1 1999, 2155-2163.
22. Weeresakare, G. M.; Xu, Q.; Rainier, J. D. Tetrahedron Lett. 2002, 43, 8913-8915.
23. Ogawa, H.; Aoyama, T.; Shioiri, T. Heterocycles 1996, 42, 75-82.
24. Sémeril, D.; Le Nôtre, J.; Bruneau, C.; Dixneuf, P. H. New J. Chem. 2001, 25, 16-18.
25. (a) Donohoe, T. J.; Guyo, P. M. J. Org. Chem. 1996, 61, 7664-7665.
26. (b) Donohoe, T. J.; Guyo, P. M.; Beddoes, R. L.; Helliwell, M. J. Chem. Soc., Perkin Trans. 1998, 1, 667-676.
27. (a) Kinsman, R.; Lathbury, D.; Vernon, P.; Gallagher, T. J. Chem. Soc. Chem. Commun. 1987, 243-244.
28. (b) Davies, I. W.; Gallagher, T.; Lamont, R. B.; Scopes, D. I. G J. Chem. Soc., Chem. Commun. 1992, 335-337.
29. (c) Amombo, M. O.; Hausherr, A.; Reissig, H. U. Synlett. 1999, 1871-1874.
30. (d) Dieter, R. K.; Yu, H. Org. Lett. 2001, 3, 3855-3858.
31. (e) Horváth, A.; Benner, J.; Bäckvall, J. E. Eur. J. Org. Chem. 2004, 3240-3243.
32. Mitasev, B.; Brummond, K. M. Synlett 2006, 3100-3104.
33. Koksch, B.; Sewald, N.; Hofmann, H. J.; Burger, K.; Jakubke, H. D. J. Pept. Sci. 1997, 3, 157-167.
34. (a) Werner, S.; Iyer, P. S. Synlett 2005, 1405-1408.
35. (b) Werner, S.; Iyer, P. S.; Fodor, M. D.; Coleman, C. M.; Twining, L. A.; Mitasev, B.; Brummond, K. M. J. Comb. Chem. 2006, 8, 368-380.
36. (a) QikProp, version 2.1; Schrödinger, Inc.: New York, 2003.
37. (b) Duffy, E. M.; Jorgensen, W. L. J. Am. Chem. Soc. 2000, 122, 2878-2888.
38. (c) Jorgensen, W. L.; Duffy, E. M. Adv. Drug Delivery Rev. 2002, 54, 355-366.
39. The term tool-like has been invoked to set the goals of this research apart from the goal of developing a drug for which druglike properties are the primary concern. For example, tool-like compounds may not obey the rule of five or other criteria for oral bioavailability, but they are important for target validation in drug discovery, see also ref 20b.
40. (a) Sauer, D. R.; Kalvin, D.; Phelan, K. M. Org. Lett. 2003, 5, 4721-4724.
41. (b) Wipf, P.; Werner, S.; Woo, G. H. C.; Stephenson, C. R. J.; Walczak, M. A. A.; Coleman, G M.; Twining, L. A. Tetrahedron 2005, 61, 11488-11500.